Research and development support services
Ended Awarded Last action
- Contract number
- 75F40123F19016
- Awardee
-
Goldbelt C6, LLC UEI LSY9B62DKAC8 Part of Goldbelt, Incorporated
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $786,929
Award facts
- Contract value 100% obligated
- $786,928.57 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Berwyn Heights, MD 20740, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$5,090 | |
| Original award | $792,019 |
About this award
The Food and Drug Administration awarded a delivery order valued at approximately $787K to Goldbelt C6, LLC, a subsidiary of Goldbelt, Incorporated, an Alaska Native Corporation headquartered in Juneau, Alaska. This firm fixed price delivery order is for Research and Development Support Services and will be performed in Berwyn Heights, Maryland, with an ultimate completion date of September 28, 2025. The award was issued on September 13, 2023, without a set-aside designation. Goldbelt C6 is a certified small disadvantaged business under the 8(a) Business Development Program and has extensive experience delivering scientific and technical services to the FDA, including toxicology research, dietary ingredient reviews, food safety analysis, and cosmetic safety assessment.
This delivery order is issued under Goldbelt C6's existing $20 million single-award indefinite delivery contract with the FDA for research and development support services, which runs through August 2028. The contractor's established track record with the FDA and its broader portfolio of federal contracts across multiple agencies—including the Department of State, Centers for Disease Control and Prevention, U.S. Coast Guard, and Defense Health Agency—positions it to effectively support the agency's mission-critical research requirements. Goldbelt C6 maintains substantial contracting capacity through six prime indefinite delivery contracts and participation in the $50 billion 8(a) STARS III government-wide acquisition contract, enabling rapid response to evolving federal agency needs.
Quick answers
Who was awarded contract 75F40123F19016?
75F40123F19016 was awarded to Goldbelt C6, LLC by Food and Drug Administration (Department of Health and Human Services) on September 13, 2023.
How much is contract 75F40123F19016 worth?
The government has obligated $786,929 on 75F40123F19016.
Is contract 75F40123F19016 an order under another contract?
Yes. 75F40123F19016 is a delivery order under 75F40123D00017, an indefinite delivery contract.
Was contract 75F40123F19016 competed?
The extent of competition for 75F40123F19016 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award